Jefferson received a $2M grant to expand it's Bioprocessing Institute
Thomas Jefferson University’s Jefferson Institute for Bioprocessing (JIB) has received a $2 million grant through the commonwealth’s Redevelopment Assistance Capital Program (RACP) to add nearly 20,000 square feet of additional academic and training space at its Lower Gwynedd (Montgomery County) training and education facility.
“The Jefferson Institute is on the cutting edge of developing advanced manufacturing technologies for next-generation biologics, including vaccines and cell and gene therapies. I have been impressed by their commitment to diversity and inclusion, as well as workforce development, working with local community colleges and employers to prepare students and professionals for the skills they need for the jobs of the future,” said Senator Collett.
Boston Consulting Group (BCG) and Thomas Jefferson University’s Institute for Bioprocessing (JIB) today launched the Digital Demonstrator for Innovation, a digitally immersive experience that helps executives understand how Industry 4.0 technologies can drive value throughout biopharma operations.
Philly native is first African-American student accepted into Thomas Jefferson University’s biopharmaceutical engineering master’s program
The Jefferson Institute for Bioprocessing is uniquely qualified to train students and industry professionals at the time it is needed most.